KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares Outstanding
Ratios

Astrana Health (ASTH) Long-Term Debt Issuances (2016 - 2025)

Astrana Health (ASTH) has disclosed Long-Term Debt Issuances for 11 consecutive years, with $707.3 million as the latest value for Q3 2025.

  • Quarterly Long-Term Debt Issuances rose 45385.53% to $707.3 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 billion through Dec 2025, up 551.23% year-over-year, with the annual reading at $1.1 billion for FY2025, 551.23% up from the prior year.
  • Long-Term Debt Issuances hit $707.3 million in Q3 2025 for Astrana Health, up from $412.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $707.3 million in Q3 2025 to a low of -$1.7 million in Q3 2023.
  • Historically, Long-Term Debt Issuances has averaged $117.3 million across 5 years, with a median of $1.6 million in 2022.
  • Biggest five-year swings in Long-Term Debt Issuances: plummeted 331.51% in 2023 and later surged 51455.56% in 2024.
  • Year by year, Long-Term Debt Issuances stood at $569000.0 in 2021, then surged by 183.3% to $1.6 million in 2022, then soared by 17550.56% to $284.5 million in 2023, then crashed by 99.45% to $1.6 million in 2024, then surged by 45385.53% to $707.3 million in 2025.
  • Business Quant data shows Long-Term Debt Issuances for ASTH at $707.3 million in Q3 2025, $412.0 million in Q1 2025, and $1.6 million in Q3 2024.